RankAlpha logo
Back to Rankings

BBIO

BridgeBioB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Positive pivotal readouts and favorable regulatory/partnering outcomes trigger re-rating toward analyst highs.
Posture
Constructive
Lead driver
Sentiment
What changed
Next scheduled catalyst: earnings 2026-10-29 · AMC.
What can break
Clinical failure or missed endpoints for key programs
Momentum
28
Value
41
Sentiment
78
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $85.79 · Bull $115.50 · Bear $42.63Analysis 2026-01-19; returns require an exact persisted reference.
Earnings
2026-10-29 · AMC
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-19 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-10-23

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions

Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $110.47
Why
Momentum28 · Δ7d +9.1
Value41 · Δ7d -0.1
Sentiment78 · Δ7d -3.3
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Confirming evidence

  • • Next scheduled catalyst: earnings 2026-10-29 · AMC.
  • • Sentiment remains the lead driver in the composite, 7D delta -3.3.

Contradictions & invalidation

  • • Clinical failure or missed endpoints for key programs
  • • Concentration risk from a small number of value-driving programs
  • • Program failures, regulatory setbacks, or dilutive financing compress valuation toward analyst lows.

Catalyst clock

2026-10-29 · AMC

Quarterly results & analyst updates

Lead driver: Sentiment · See AI snapshot
Momentum
28
8% active weight
Current posture
7d trendSoftening
Δ7d
+9.1
Δ21d
+25.8
Value
41
47% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.4
Sentiment
78
45% active weight
Current posture
7d trendSoftening
Δ7d
-3.3
Δ21d
-15.4
Why this grade

Composite grade B. Momentum 28.2 / Value 40.6 / Sentiment 78.0

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-01-19. Scenario method

B+
Bull case
20%
Probability
Target price
$115.50
Analysis reference price unavailable
Analysis 2026-01-19 · RankAlpha Sentiment AI
Most likely
B
Base case
60%
Probability
Target price
$85.79
Analysis reference price unavailable
Analysis 2026-01-19 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$42.63
Analysis reference price unavailable
Analysis 2026-01-19 · RankAlpha Sentiment AI
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$13.4B
Beta
1.13
Shares Out
195.49M
P/E (TTM) · Derived
-18.1
P/S (TTM)
39.99
P/FCF (TTM) · Derived
-30.56
Rev YoY
+120.4%
EPS YoY
-18.6%
Gross Margin
+94.1%
Op Margin
-67.0%
Net Debt
$2.14B
Current Ratio
1.23
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data